<DOC>
	<DOCNO>NCT02664571</DOCNO>
	<brief_summary>The main objective study compare distribution Florbetaben ( NEURACEQ : FBB ) brain amyloid cerebral angiopathy ( ACA ) manifest isolated hemosiderosis non-demented patient observe healthy subject , patient ACA lobar hematoma ( ) patient Alzheimer 's dementia without MRI sign favor ACA .</brief_summary>
	<brief_title>Florbetaben Amyloid Plaque Marker Elderly Patients With Focal Disseminated Superficial Hemosiderosis</brief_title>
	<detailed_description>The secondary objective study compare among group : A . The associated micro-bleeds . B . Associated leukoencephalopathy . C. Contrast observe lobar Virchow-Robin perivascular space . D. Apolipoprotein E genotype .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Amyloidosis</mesh_term>
	<mesh_term>Hemosiderosis</mesh_term>
	<mesh_term>Plaque , Amyloid</mesh_term>
	<criteria>Inclusion Criteria patient amyloid cerebral angiopathy isolate hemosiderosis : The patient must give his/her inform sign consent The patient must insure beneficiary health insurance plan The patient single multiple focal spontaneous hemosiderosis objectify MRI The patient dementia ( Mini Mental State score &gt; 27 ) Inclusion Criteria patient amyloid cerebral angiopathy lobar hematoma ( ) : The patient must give his/her inform sign consent The patient must insure beneficiary health insurance plan The patient one spontaneous lobar hematoma without hemosiderosis objectify MRI The patient dementia ( Mini Mental State score &gt; 27 ) Inclusion Criteria patient Alzheimer 's type dementia without MRI sign favor amyloid cerebral angiopathy : The patient must give his/her inform sign consent The patient must insure beneficiary health insurance plan The patient Alzheimer 's dementia ( Mini Mental State score &lt; 24 ) without hemosiderosis previous lobar hematoma history brain lesion see MRI Inclusion Criteria health volunteer : The subject must give his/her inform sign consent The subject must insure beneficiary health insurance plan Healthy volunteer without cerebral neurological history normal MRI The subject dementia ( Mini Mental State score &gt; 27 ) Exclusion Criteria patient amyloid cerebral angiopathy isolate hemosiderosis : The patient participate another interventional study The patient exclusion period determine previous study The patient judicial protection The subject ( next kin legal representative ) refuse sign consent It possible give subject his/her representative inform information The patient contraindication perform MRI The patient acute phase ( tracer bind case large hematoma ) Exclusion Criteria patient amyloid cerebral angiopathy lobar hematoma ( ) : The patient participate another interventional study The patient exclusion period determine previous study The patient judicial protection The subject ( next kin legal representative ) refuse sign consent It possible give subject his/her representative inform information The patient contraindication perform MRI The patient acute phase ( tracer bind case large hematoma ) Exclusion Criteria fpr patient Alzheimer 's type dementia without MRI sign favor amyloid cerebral angiopathy : The patient participate another interventional study The patient exclusion period determine previous study The patient judicial protection The subject ( next kin legal representative ) refuse sign consent It possible give subject his/her representative inform information The patient contraindication perform MRI The patient acute phase ( tracer bind case large hematoma ) Haemosiderosis history lobar hematoma visible cerebral history MRI Exclusion Criteria healthy volunteer : The subject participate another interventional study The subject exclusion period determine previous study The subject judicial protection The subject ( next kin legal representative ) refuse sign consent It possible give subject his/her representative inform information The subject contraindication perform MRI Abnormal MRI The group match accord sex age ( increment 5 year ) extent possible . Because amyloid cerebral angiopathy rare condition , match two factor may difficult achieve . We therefore anticipate appropriate focus matching age .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>